• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺特异性抗原:根治性前列腺切除术后尽管肿瘤进展但仍检测不到。

Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy.

作者信息

Goldrath D E, Messing E M

机构信息

Department of Surgery, University of Wisconsin School of Medicine, Madison 53792.

出版信息

J Urol. 1989 Oct;142(4):1082-4. doi: 10.1016/s0022-5347(17)38998-x.

DOI:10.1016/s0022-5347(17)38998-x
PMID:2477560
Abstract

Prostate specific antigen was not detectable in 2 men with documented prostate cancer progression after radical prostatectomy. Possible explanations for prostate specific antigen remaining zero in these situations are discussed. We conclude that while monitoring prostate specific antigen is of great value in the followup of patients with prostatic cancer, it has not replaced more standard means of followup.

摘要

在2例根治性前列腺切除术后有前列腺癌进展记录的男性患者中,未检测到前列腺特异性抗原。本文讨论了在这些情况下前列腺特异性抗原保持为零的可能原因。我们得出结论,虽然监测前列腺特异性抗原在前列腺癌患者的随访中具有重要价值,但它尚未取代更标准的随访方法。

相似文献

1
Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy.前列腺特异性抗原:根治性前列腺切除术后尽管肿瘤进展但仍检测不到。
J Urol. 1989 Oct;142(4):1082-4. doi: 10.1016/s0022-5347(17)38998-x.
2
The value of serum prostate specific antigen determinations before and after radical prostatectomy.根治性前列腺切除术前和术后血清前列腺特异性抗原测定的价值。
J Urol. 1989 Apr;141(4):873-9. doi: 10.1016/s0022-5347(17)41037-8.
3
Predictive factors and the important role of detectable prostate-specific antigen for detection of clinical recurrence and cancer-specific mortality following robot-assisted radical prostatectomy.机器人辅助根治性前列腺切除术后预测临床复发和癌症特异性死亡率的相关因素和可检测前列腺特异性抗原的重要作用。
Clin Transl Oncol. 2018 Aug;20(8):1004-1010. doi: 10.1007/s12094-017-1812-1. Epub 2017 Dec 14.
4
Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.前列腺特异性抗原在前列腺腺癌诊断与治疗中的应用。II. 接受根治性前列腺切除术的患者。
J Urol. 1989 May;141(5):1076-83. doi: 10.1016/s0022-5347(17)41175-x.
5
Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.前列腺特异性酸性磷酸酶和前列腺特异性抗原在A2期前列腺腺癌中的免疫组织化学定位:预后意义
Hum Pathol. 1984 Sep;15(9):853-9. doi: 10.1016/s0046-8177(84)80146-x.
6
Undetectable serum prostate-specific antigen associated with metastatic prostate cancer: a case report and review of the literature.不可检测的血清前列腺特异性抗原与转移性前列腺癌:一例病例报告及文献复习
Am J Clin Oncol. 1998 Aug;21(4):323-6. doi: 10.1097/00000421-199808000-00001.
7
Patient evaluation if prostate-specific antigen becomes elevated following radical prostatectomy or radiation therapy.在前列腺癌根治术或放射治疗后,如果前列腺特异性抗原升高,对患者进行评估。
Urol Clin North Am. 1994 Nov;21(4):677-85.
8
Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.淋巴管浸润是前列腺腺癌的一个独立预后因素。
J Urol. 2005 Dec;174(6):2181-5. doi: 10.1097/01.ju.0000181215.41607.c3.
9
Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.前列腺特异性抗原作为前列腺腺癌的血清标志物。
N Engl J Med. 1987 Oct 8;317(15):909-16. doi: 10.1056/NEJM198710083171501.
10
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.临床局限性前列腺癌根治性前列腺切除术后的生化(前列腺特异性抗原)复发概率。
J Urol. 2003 Feb;169(2):517-23. doi: 10.1097/01.ju.0000045749.90353.c7.

引用本文的文献

1
Incidental detection of localized prostate cancer with low PSA by computed tomography scan: A report of two cases.计算机断层扫描偶然发现低前列腺特异性抗原水平的局限性前列腺癌:两例报告。
Clin Case Rep. 2022 Dec 15;10(12):e6736. doi: 10.1002/ccr3.6736. eCollection 2022 Dec.
2
Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancer.临床局限性前列腺癌根治性治疗后前列腺特异性抗原生化复发男性的评估与治疗
Rev Urol. 2001 Spring;3(2):72-84.
3
Is DRE essential for the follow up of prostate cancer patients? A prospective audit of 194 patients.
直肠指检对前列腺癌患者的随访至关重要吗?对194例患者的前瞻性审计。
BMC Urol. 2005 Jan 10;5:1. doi: 10.1186/1471-2490-5-1.
4
What does prostate-specific antigen recurrence mean?前列腺特异性抗原复发是什么意思?
Curr Urol Rep. 2000 May;1(1):28-35. doi: 10.1007/s11934-000-0032-2.
5
Tibia metastasis without prostate specific antigen (PSA) increase following radical vesiculo-prostatectomy.根治性膀胱前列腺切除术后出现胫骨转移但前列腺特异性抗原(PSA)未升高。
Int Urol Nephrol. 2000;32(2):281-4. doi: 10.1023/a:1007142910479.
6
Maximal androgen blockade in combination with methotrexate for treatment of metastatic prostate cancer.最大雄激素阻断联合甲氨蝶呤治疗转移性前列腺癌。
J Cancer Res Clin Oncol. 1996;122(3):171-76. doi: 10.1007/BF01366958.